NASDAQ:IOVA - Iovance Biotherapeutics, Inc.
$10.84
 $0.07
+0.65%
4:00PM EDT
2019-04-18
Iovance Biotherapeutics, Inc., formerly Lion Biotechnologies, Inc., incorporated on September 17, 2007, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company's lead program is an adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors, for the treatment of metastatic melanoma. As of December 31, 2016, the Company had an on-going Phase II clinical trial of its lead product candidate, LN-144, TIL for the treatment of metastatic melanoma. The Company is developing LN-145 to treat cervical and head and neck cancers. The Company is collaborating with the National Cancer Institute (NCI) to evaluate unmodified TIL in other solid tumor indications, such as ocular (uveal) melanoma, bladder, breast and lung cancer. The Company is also collaborating with Karolinska University Hospital to conduct clinical trials of TIL manufactured using a cytokine cocktail for expansion in pancreatic cancer and glioblastoma.The Company is collaborating with the NCI to evaluate TIL in combination with the checkpoint inhibitor, Keytruda (pembrolizumab). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  IOVA     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 54   203. 85   241. 91  
42 stocks rank:  3. 79 K 1. 44 K 1. 05 K
# analyst opinions:  7. 00   14. 51   13. 97  
mean recommendation:  1. 50   2. 09   2. 01  

quick ratio:  32. 54   5. 27   1. 81  
current ratio:  33. 02   5. 62   2. 25  

target price low:  20. 00   84. 80   115. 21  
target price avg:  25. 29   111. 51   137. 51  
target price high:  30. 00   135. 81   157. 84  
1-yr high:  17. 70   114. 23   138. 78  
last close:  10. 84   87. 66   116. 69  
50-day avg:  10. 42   95. 54   123. 44  
200-day avg:  11. 20   94. 25   121. 11  
1-yr low:  7. 51   72. 78   98. 34  
volume:  951. 41 K 4. 11 M 8. 07 M
50-day avg volume:  1. 07 M 2. 76 M 5. 02 M
200-day avg volume:  1. 26 M 2. 92 M 4. 59 M

1-day return:  0. 65 % -0. 41 % 0. 07 %
this week return:  -6. 79 % -5. 74 % -4. 11 %
12-wk return:  20. 85 % 1. 61 % -0. 05 %
52-wk return:  -25. 72 % 3. 12 % 8. 78 %

enterprise value (EV):  869. 36 M 48. 94 B 114. 64 B
market cap:  1. 34 B 43. 07 B 104. 73 B
EBITDA:  -127. 30 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -6. 83   4. 22   12. 73  
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -123. 58 M 2. 20 B 4. 20 B

shares outstanding:  123. 42 M 571. 70 M 1. 24 B
shares:  92. 62 M 571. 81 M 1. 23 B
shares short:  10. 53 M 10. 17 M 13. 00 M
shares short prior month:  10. 37 M 9. 54 M 17. 33 M
short ratio:  11. 22   5. 41   3. 28  
short % of float:  13. 03 % 5. 45 % 2. 38 %
total cash/share:  3. 80   11. 14   9. 33  
total cash:  468. 52 M 6. 71 B 7. 15 B
free cash flow:  -58. 43 M 3. 58 B 2. 96 B
operating cash flow:  -101. 25 M 4. 15 B 4. 30 B

book value:  3. 78   12. 78   26. 92  
price/book:  2. 87   3. 06   -1. 74  
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  -24. 78 % --- ---
1-yr mean volatility:  -0. 02 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 27   2. 40   4. 10  
forward EPS:  -1. 34   3. 97   7. 13  
P/E:  -8. 54   13. 63   22. 72  
forward P/E:  -8. 09   -15. 95   13. 99  
PE/G:  1. 06   -1. 65   -1. 32  
growth:  -8. 08 % 127. 12 % 29. 61 %
earnings high:  -0. 18   1. 00   1. 66  
earnings avg:  -0. 29   0. 77   1. 53  
earnings low:  -0. 37   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -25. 20 % -2. 75 % 4. 55 %
return on equity:  -40. 41 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  2. 07   1. 25   0. 93  
sharpe (1yr):  -0. 08   0. 37   0. 70  

held % insiders:  1. 14 % 6. 39 % 3. 38 %
held % institutions:  102. 66 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : IOVA
.    + 2.022 =         2.022 :: INITIAL WEIGHT
.   + 61.642 =        63.665 :: inverse volume-to-price addition
.   + 46.789 =       110.454 :: spline projection addition
.    x 3.807 =       420.477 :: 13 weeks' performance factor
.    x 0.826 =       347.163 :: one-year gains+dividend factor
.    x 1.431 =       496.937 :: industry recommendation factor
.    x 2.927 =      1454.287 :: symbol recommendation factor
.    x 0.997 =      1450.622 :: return on assets factor
.    x 0.996 =       1444.76 :: return on equity factor
.    x 5.112 =      7384.927 :: current ratio factor
.    x 1.016 =      7501.082 :: quick ratio factor
.    x 1.044 =      7828.221 :: short ratio factor
.    x 2.029 =     15881.112 :: price-to-book factor
.    x 1.069 =     16968.993 :: 5-day avg > 50-day avg
.    x 2.013 =     34163.696 :: P/E weight
.    x 0.986 =      33700.15 :: PE/G factor
.    x 1.325 =     44657.401 :: beta factor
.    x 0.077 =      3436.566 :: sharpe factor
.    x 2.018 =      6933.566 :: target low factor
.    x 1.385 =      9601.989 :: target mean factor
.    x 1.133 =     10878.558 :: target high factor
.     x 1.31 =     14249.691 :: industry 2-weeks return factor
.    x 0.926 =     13198.245 :: "drift" penalty 2 days ago
.    x 0.922 =      12172.38 :: "drift" penalty 4 days ago
.    x 0.972 =     11831.635 :: overall "drift" factor
.    x 0.999 =     11819.265 :: largest single-day jump factor
.    x 0.158 =      1864.237 :: low price factor
.      x 1.0 =      1863.935 :: factor hist industry gain for week 16
.   cubeRoot =        12.307 :: reduced to standardize
.   - 23.081 =         0.538 :: add/subtract for performance
.                      0.538 :: FINAL WEIGHT for NASDAQ:IOVA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org